HealthEquity (NASDAQ:HQY) Raised to “Buy” at Wall Street Zen

HealthEquity (NASDAQ:HQY) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

HQY has been the subject of several other research reports. Citizens Jmp increased their price objective on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. BTIG Research boosted their target price on shares of HealthEquity from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Friday, July 24th. Wells Fargo & Company set a $111.00 price target on shares of HealthEquity in a research note on Monday, June 1st. Royal Bank Of Canada increased their price target on shares of HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a report on Wednesday, June 3rd. Finally, Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Eleven research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and a consensus target price of $110.93.

HealthEquity Stock Performance

Shares of HQY stock opened at $105.41 on Friday. The company has a market cap of $8.81 billion, a price-to-earnings ratio of 39.48, a price-to-earnings-growth ratio of 1.77 and a beta of 0.21. The stock has a 50 day simple moving average of $96.64 and a 200-day simple moving average of $87.20. HealthEquity has a 12-month low of $72.76 and a 12-month high of $107.62. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. On average, equities analysts forecast that HealthEquity will post 3.92 EPS for the current year.

Insider Buying and Selling

In related news, EVP Delano Ladd sold 7,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares of the company’s stock, valued at $8,202,690. This trade represents a 7.60% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director directly owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 17,905 shares of company stock worth $1,651,280 in the last quarter. Company insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Acumen Wealth Advisors LLC acquired a new stake in HealthEquity in the 4th quarter valued at about $27,000. Caitong International Asset Management Co. Ltd increased its holdings in HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after acquiring an additional 293 shares in the last quarter. Aster Capital Management DIFC Ltd purchased a new position in HealthEquity during the 4th quarter valued at about $28,000. Leonteq Securities AG raised its position in HealthEquity by 159.9% during the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after acquiring an additional 235 shares during the last quarter. Finally, Axiom Investment Management LLC acquired a new position in HealthEquity during the first quarter worth about $33,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.